Premium Nahrungsergänzungsmittel | artgerecht

Hilar Lymph Node Tuberculosis: Causes and Treatment

Hilar lymph node tuberculosis is a form of TB affecting the lymph nodes at the lung hilum. It occurs most frequently in children and requires prompt treatment.

Regular tips about health Regular tips about health

Things worth knowing about "Hilar Lymph Node Tuberculosis"

Hilar lymph node tuberculosis is a form of TB affecting the lymph nodes at the lung hilum. It occurs most frequently in children and requires prompt treatment.

What is Hilar Lymph Node Tuberculosis?

Hilar lymph node tuberculosis is a specific form of tuberculosis (TB) in which infection with the bacterium Mycobacterium tuberculosis primarily affects the lymph nodes located at the lung hilum -- the central region where blood vessels, bronchi, and lymphatic vessels enter the lungs. These lymph nodes are part of the immune system and respond to infection with swelling and inflammation. This form is also referred to as primary tuberculosis and is most common in children and adolescents, although adults can also be affected.

Causes

Hilar lymph node tuberculosis is caused by infection with Mycobacterium tuberculosis, an acid-fast rod-shaped bacterium. Transmission occurs through:

Droplet infection: Inhalation of airborne particles containing the bacterium, released by infected individuals when coughing, sneezing, or speaking.
Close contact with a person suffering from active pulmonary tuberculosis.

Following the initial lung infection (primary infection), bacteria travel via the lymphatic system to the hilar lymph nodes, triggering a pronounced inflammatory response. The resulting primary complex consists of the lung focus and the affected hilar lymph nodes.

Symptoms

Symptoms can vary and are not always clearly defined. Common signs of hilar lymph node tuberculosis include:

Persistent low-grade fever lasting several weeks
Night sweats
Unintentional weight loss and loss of appetite
Chronic cough, sometimes with mucus production
Fatigue and general malaise
In children: failure to thrive
In rare cases: breathing difficulties due to compression of the airways by significantly enlarged lymph nodes (mediastinal compression)

In many cases, especially in the early stages, the disease may be asymptomatic or present with only mild symptoms.

Diagnosis

Diagnosing hilar lymph node tuberculosis requires several investigative steps:

Imaging

Chest X-ray: Reveals enlarged hilar lymph nodes (unilateral or bilateral hilar widening) and possible pulmonary infiltrates.
Chest computed tomography (CT): Provides a more detailed assessment of lymph nodes and helps differentiate TB from other causes of hilar enlargement.

Microbiological and Immunological Tests

Tuberculin skin test (Mantoux test): Assesses the immune response to tuberculin antigens.
Interferon-gamma release assays (IGRA): Blood tests detecting sensitization to Mycobacterium tuberculosis (e.g., QuantiFERON-TB Gold).
Sputum examination: Microscopy and culture for acid-fast bacilli; often difficult to perform in young children.
Bronchoscopy with bronchoalveolar lavage (BAL): Collection of airway secretions for microbiological analysis.
Lymph node biopsy: In unclear cases, tissue sampling for histological and microbiological confirmation may be required.

Additional Tests

Blood count and inflammatory markers (ESR, CRP)
PCR-based nucleic acid amplification tests for rapid pathogen detection

Treatment

Treatment of hilar lymph node tuberculosis follows international TB management standards and involves a combination of multiple antibiotics to prevent the development of drug resistance.

Standard Therapy (WHO Recommendation)

Intensive phase (2 months): Four-drug regimen comprising Isoniazid (INH), Rifampicin (RMP), Pyrazinamide (PZA), and Ethambutol (EMB).
Continuation phase (4 months): Ongoing treatment with Isoniazid and Rifampicin.

The total treatment duration is typically 6 months. In cases of complications or drug-resistant strains, treatment may be extended or modified.

Special Considerations in Children

In children, drug dosages are adjusted according to body weight. Pyridoxine (Vitamin B6) supplementation is often co-administered with Isoniazid therapy to prevent peripheral neuropathy. Regular monitoring of liver function tests is important throughout treatment.

Supportive Measures

Adequate nutrition and vitamin supplementation
Regular medical follow-up and therapy monitoring
In severe cases with airway compression: corticosteroids as adjunctive anti-inflammatory therapy

Prognosis

With early diagnosis and consistent treatment, the prognosis for hilar lymph node tuberculosis is generally favorable. Most patients recover completely. Without treatment, however, the disease can progress and lead to serious complications such as miliary tuberculosis (hematogenous spread of bacteria) or tuberculous meningitis.

References

World Health Organization (WHO): Tuberculosis. Global Tuberculosis Report 2023. Geneva: WHO, 2023.
Marais BJ et al.: The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. International Journal of Tuberculosis and Lung Disease, 2004; 8(4): 392-402.
Starke JR, Donald PR (eds.): Handbook of Child and Adolescent Tuberculosis. Oxford University Press, 2016.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category